Objective-To determine the role of prostacyclin (PGI 2 ) in protecting endothelial cells (ECs) from apoptosis and elucidate the protective mechanism. Methods and Results-To evaluate the effect of PGI 2 on EC survival, we treated ECs with Ad-COX1/PGIS (Ad-COPI), which augmented selectively PGI 2 production or carbaprostacyclin (cPGI 2 ) followed by H 2 O 2 for 4 hours. Ad-COPI inhibited annexin V-positive cells and blocked caspase 3 activation. cPGI 2 inhibited apoptosis in a concentrationdependent manner. L-165041 had a similar effect, suggesting the involvement of peroxisome proliferator-activated receptor-␦ (PPAR␦). ECs expressed functional PPAR␦. PPAR␦ overexpression enhanced whereas PPAR␦ knockdown by small interfering RNA abrogated the antiapoptotic action of cPGI 2 and L-165041. Our results show for the first time that PGI 2 stimulated 14-3
V ascular endothelial cells (ECs) are metabolically active, capable of synthesizing an array of compounds in response to exogenous stimulation. These molecules play crucial roles in protecting vascular integrity. Among the molecules, prostacyclin (PGI 2 ) inhibits platelet aggregation, regulates vascular tone, antagonizes the actions of thromboxane A 2 , and protects tissues from apoptosis. [1] [2] [3] [4] The biological actions of PGI 2 are mediated by a PGI 2 -specific Gs-coupled receptor that signals via the cAMP-dependent protein kinase A pathway. 5 Recent studies suggest that certain PGI 2 actions may be mediated via the peroxisome proliferator-activated receptor-␦ (PPAR␦) pathway. Several PGI 2 synthetic analogs such as carbaprostacyclin (cPGI 2 ) have been shown to bind and activate PPAR␦. 6 PPAR␦ is involved in controlling keratinocyte and cancer cell apoptosis. 7,8 cPGI 2 has been shown to protect renal cells from hypertonicity-induced apoptosis, which was attributed to PPAR␦ activation. 9 It is conceivable that EC-derived PGI 2 production in response to exogenous stimuli may, in an autocrine or paracrine manner, protect ECs from apoptosis. However, this notion has not been supported by reported data. The aims of this study were, hence, to determine whether PGI 2 protects ECs from H 2 O 2 -induced apoptosis and to elucidate the protective mechanism. Because authentic PGI 2 is unstable and unsuitable for this study, we transduced human umbilical vein ECs (HUVECs) with an adenoviral vector containing a bicistronic cyclooxygenase-1 (COX-1) and PGI 2 synthase (PGIS) construct (Ad-COPI), which selectively augment PGI 2 synthesis in HUVECs. 10 ECs synthesize PGI 2 by 3 enzymatic steps: (1) activation of an 85-kDa cytosolic phospholipase A 2 , which catalyzes release of arachidonic acid from membrane phospholipids; (2) conversion of arachidonic acid into prostaglandin H 2 by cyclooxygenases (COX-1 and COX-2); and (3) conversion of prostaglandin H 2 into PGI 2 by PGIS. 11 These enzymes are colocalized and functionally coupled. 12, 13 COX-1 and PGIS undergo autoinactivation during catalysis, thereby limiting the extent of PGI 2 synthesis. 14 -16 Limitation of PGI 2 production is circumvented by Ad-COPI-induced cooverexpression of COX-1 and PGIS, which selectively augments PGI 2 production without a concurrent increase in the production of other eicosanoids. 10 Thus, Ad-COPI is well suited for evaluating the effect of authentic PGI 2 on EC survival. The results show that Ad-COPI suppressed annexin V-positive cells and caspase 3 activation. cPGI 2 protected HUVECs from apoptosis in a concentration-dependent manner. Furthermore, L-165041, a selective PPAR␦ ligand, suppressed H 2 O 2 -induced apoptosis, suggesting the involvement of PPAR␦. HUVECs expressed functional PPAR␦. Overexpression of PPAR␦ by Ad-PPAR␦ enhanced whereas knockdown of PPAR␦ with small interfering RNA (siRNA) abrogated the antiapoptotic action of cPGI 2 and L-165041. Our results reveal for the first time that PGI 2 upregulated 14-3-3, especially 14-3-3, in a PPAR␦-dependent manner. cPGI 2 induced binding of PPAR␦ to PPAR response elements (PPREs), thereby activating 14-3-3 promoter activity. 14-3-3 is a member of 14-3-3 family, which binds phosphorylated Bad and sequesters Bad in the cytosol. [17] [18] [19] [20] Our results show that 14-3-3 upregulation amplified Bad binding and reduced Bad translocation to mitochondria, whereby it inhibited cytochrome c release, caspase 3 activation, and EC apoptosis.
Materials and Methods

Recombinant Adenoviral Vectors
Ad-COPI vectors were generated by homologous recombination and amplified in 293 cells as described previously. 10 An empty adenovirus (Ad-null) or Ad-GFP was used as a control. Ad-PPAR␦ was kindly provided by Drs Kinzler and Vogelstein at Johns Hopkins University, Baltimore, Md. The recombinant viruses were purified by CsCl density-gradient centrifugation, and the virus titers were determined by a plaque assay as described previously. 10
Cell Culture and Treatment
HUVECs were prepared from freshly obtained umbilical veins and cultured as described previously. 21 In initial experiments, HUVECs (at passage 3 or 4) grown in a 6-well plate were treated with various concentrations of H 2 O 2 for various periods of time, and apoptosis was determined. We found treatment of HUVECs with 0.5 mmol/L H 2 O 2 for 4 hours to be optimal. To evaluate the effects of cPGI 2 and L-165041 on apoptosis, HUVECs were pretreated with either compound for 4 hours before treatment with H 2 O 2 in serum-free medium for 4 hours. Based on our previous experimental results, 10 we infected HUVECs with recombinant adenoviruses for 48 hours. ECV304 cells were maintained in DMEM containing 10% FBS. For induction of ECV304 apoptosis, cells were treated with 2 mmol/L H 2 O 2 for 8 hours.
Assay of Apoptosis
Apoptosis was analyzed by flow cytometry using annexin V staining. Cells were washed with PBS and incubated with a fluorescein isothiocyanate-labeled annexin V antibody (Beckman Coulter). The labeled cells were analyzed by flow cytometry (Beckman Coulter Epics XL). Apoptosis was also analyzed by incubating cells with 1 g/mL Hoechst 33258 for 15 minutes and counting positively stained cells by fluorescent microscopy. Caspase-3 activity was assayed by flow cytometry using a caspase-3 assay kit (Calbiochem). Cytochrome c release was analyzed using immunofluorescent microscopy by a method described previously. 22 The images were processed by Adobe Photoshop software. In all the assays, the results were expressed as percentages of positively stained cells.
Plasmid Constructs and Luciferase Reporter Assay
To construct human 14-3-3 vector, the complete coding sequence of 14-3-3 was amplified by polymerase chain reaction (PCR) and cloned into pCDNA3.1ϩ vector (Invitrogen). siRNA of PPAR␦ (sense sequence: ACAGATGAAGACAGATGCACC) was purchased from Applied Biosystems. To achieve high transfection efficiency, the endothelial-like ECV304 cells were transfected with 14-3-3 vector or siRNA-PPAR␦ by Effectene transfection kit (Quiagene). For cloning 14-3-3 promoter, a 1.6-kb (Ϫ1625 to ϩ24) 5Ј-flanking region of human genomic sequence was amplified by PCR and cloned into pGL3 luciferase reporter. 5Ј-deletion constructs (Ϫ1348 to ϩ24, Ϫ787 to ϩ24, Ϫ412 to ϩ24 and Ϫ47 to ϩ24) were amplified by PCR and subcloned to pGL3 vector. PPAR␦-specific response element reporter 7 was kindly provided by Drs Kinzler and Vogelstein. For the luciferase assay, ECV304 cells were transfected with reporter constructs by Fugene 6 transfection reagent (Roche) for 48 hours. After treatment with cPGI 2 or other compounds, cells were lysed, luciferase activity was measured using a kit from Promega, and the emitted light was determined in a luminometer. Protein concentrations of cell lysates were determined by a protein assay kit (Bio-Rad). Luciferase activity was expressed as relative light unit/g protein.
Preparation of Mitochondrial Fraction
Mitochondrial fractions were prepared by a mitochondria isolation kit (Sigma) as described previously. 22 Nuclear and cytosolic fractions were removed by 2-step gradient centrifugation, and the pellet-containing mitochondria was collected and stored at Ϫ20°C. heat shock protein 60 (Hsp60) was used as a mitochondrial marker. Immunoprecipitation cPGI 2 -or L-165041-treated HUVECs were harvested and immunoprecipitated with a 14-3-3 antibody. The immunoprecipitated complex was pulled down with protein A/G-agarose (Santa Cruz Biotechnology). After washing 5ϫ, the proteins were analyzed by Western blotting using a Bad antibody.
Western Blot Analysis
A total of 25 g of cell lysate proteins were applied to each lane and analyzed by Western blots as described previously. 21 Rabbit polyclonal antibodies against 14-3-3 isoforms (, ␥, , and , diluted at 1:250 each) goat polyclonal antibodies against COX-1 (1:1000), and Hsp60 (1:2000) 14-3-3 isoforms (, , and ␤; diluted at 1:500 each) were purchased from Santa Cruz Biotechnology. Rabbit polyclonal antibody against PPAR␦ (1:500) was obtained from Cayman Chemical. Rabbit polyclonal antibodies against cleaved poly(ADPribose)polymerase (PARP) (1:500) and Bad (1:500) were purchased from Cell Signaling. Rabbit polyclonal antibody against PGIS was prepared as described previously. 23 
Chromatin Immunoprecipitation
The assay was done as described previously. 24 The primers for amplifying PPRE-containing region are: 5Ј primer: Ϫ1625 CCAAGC-GCCAGAAGCTG AAG Ϫ1606 , and 3Ј primer: Ϫ1348 GAGACAGAGT-TGTGCTCTTG Ϫ1329 and non-PPRE region are: 5Ј primer Ϫ412 CGT-TACAGCCTCCGTCGTTC Ϫ393 , and 3Ј primer ϩ4 GATGATC-GAGAGGATCTGGTG ϩ24 . The resulting products of 297 bp and 436 bp, respectively, were separated by agarose gel electrophoresis. Putative PPAR-retinoid X receptor (RXR) binding sites with typical AGGTCA-X-AGGTCA motif (X denotes any nucleotide) on 14-3-3 promoter region were analyzed with P-Match 1.0 software (gene-regulation biological databases).
Statistical Analysis
ANOVA software was used to determine statistical differences of apoptosis, caspase 3 activity, and luciferase activity between groups. A P value Ͻ0.05 is considered to be statistically significant.
Results
PGI 2 Inhibited HUVEC Apoptosis Via PPAR␦ Activation
To evaluate the effect of PGI 2 on apoptosis, we transduced HUVECs with Ad-COPI for 48 hours, which increased equivalently COX-1 and PGIS protein levels and selectively augmented PGI 2 synthesis without an increase in other eicosanoids as reported previously (supplemental Figure I , available online at http://atvb.ahajournals.org). Ad-COPI suppressed H 2 O 2 -induced HUVEC apoptosis ( Figure 1A ) and caspase 3 activation (supplemental Figure  IIA) . cPGI 2 reduced annexin V-positive cells induced by H 2 O 2 in a concentration-dependent manner ( Figure 1B) , whereas PGE 2 at 50 mol/L did not have an effect (data not shown). cPGI 2 suppressed caspase 3 activation (supplemental Figure IIB ). L-165041 also suppressed H 2 O 2induced annexin V cells ( Figure 1C ), suggesting the involvement of PPAR␦. Because little was known about the function of endothelial PPAR␦, we determined the expression of PPAR␦ proteins in HUVECs by Western blotting. Basal PPAR␦ was detected, which was increased by cPGI 2 or L-165041 (supplemental Figure IIIA) . The PPAR␦ proteins in ECs are functionally active because a luciferase reporter containing PPREs was activated by cPGI 2 in a concentration-dependent manner (Figure 2A ). L-165041 induced PPRE reporter expression in a concentration-dependent manner identical to cPGI 2 (data not shown).
To determine the role of PPAR␦ in regulating the antiapoptotic activity of PGI 2 , we transduced HUVECs with Ad-PPAR␦, which, as expected, increased PPAR␦ protein levels (data not shown). Coinfection of HUVECs with Ad-PPAR␦ and Ad-COPI augmented the PPRE reporter response by 4-fold over that infected with Ad-GFP ( Figure 2B ). Conversely, PPAR␦ knockdown with siRNA abrogated the PPRE reporter activity induced by cPGI 2 or L-165041 ( Figure 2C ). Ad-PPAR␦ reduced H 2 O 2 -induced Hoechst-positive cells ( Figure 3A) , and caspase 3 activation (supplemental Figure IIC) to a similar extent, and knockdown of PPAR␦ expression abrogated the antiapoptotic action of cPGI 2 and L-165041 ( Figure 3B ). Together, these results suggest an essential role of PPAR␦ activation in PGI 2 -mediated antiapoptotic action.
Upregulation of 14-3-3 Proteins by PPAR␦ Activation
We hypothesized that PPAR␦ suppresses apoptosis by upregulating a survival factor in ECs. We screened a number of factors and identified 14-3-3 as a potential target. HUVECs expressed predominantly 14-3-3, , , and ␥ isoforms ( Figure 4A ). 14-3-3 ␤, , and proteins were barely detectable ( Figure 4A ). 14-3-3 was increased by cPGI 2 and L-165041 to a similar extent (Ͼ3-fold). 14-3-3 and 14-3-3 were increased by a lesser extent, whereas 14-3-3␥ was unaltered ( Figure 4A ). We focused on 14-3-3 in our subsequent experiments. Ad-PPAR␦ increased 14-3-3 by Ϸ2-fold and augmented the effect of cPGI 2 or L-165041 by an additional 2-fold ( Figure 4B ). 
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PPAR␦ siRNA abrogated 14-3-3 protein levels induced by cPGI 2 or L-165041 ( Figure 4C ). The control siRNA vector had no effect. Together, these results indicate that 14-3-3 expression is regulated by PPAR␦ activation.
Requirement of PPREs for PGI 2 -Induced 14-3-3 Transcriptional Activation
To determine whether PGI 2 stimulates 14-3-3 expression via PPAR␦-mediated transcriptional activation, we transfected ECs with the 1.6-kb (Ϫ1625 to ϩ24) 14-3-3 promoter vector. cPGI 2 and L-165041 increased the luciferase activity by Ϸ2-fold over the control (supplemental Figure IIIB) , which was abrogated by specific PPAR␦ siRNA ( Figure 5A ). Analysis of this promoter region with P-Match 1.0 revealed 3 contiguous canonical PPREs located at Ϫ1426/Ϫ1438, Ϫ1444/Ϫ1456, and Ϫ1465/ Ϫ1477. To determine whether they are required for 14-3-3 promoter activity, we constructed several 5Ј-deletion mutants into pGL3 expression vector and transfected them into ECV304. Ad-COPI increased the wild-type (p1625) promoter activity, which was enhanced by Ad-PPAR␦ ( Figure 5B ). Deletion of the PPRE-containing region such as in the p1348 mutant abolished the response to Ad-COPI and Ad-PPAR␦. Shorter 5Ј-deletion mutants (ie, p787 and p412) failed to respond to Ad-COPI or Ad-PPAR␦ but retained the basal promoter activity. Basal promoter activity was completely abolished in the p47 mutant ( Figure  5B ). To ascertain PPAR␦ binding to 14-3-3 promoter, we performed chromatin immunoprecipitation with a PPAR␦specific antibody. There was little basal PPAR␦ binding to 14-3-3, and its binding was enhanced by cPGI 2 and L-165041 to a similar extent ( Figure 5C ). As controls, PPAR␦ binding was not detected with nonimmune IgG or with a DNA sequence located at the proximal region of the 14-3-3 promoter ( Figure 5C ).
14-3-3 Protected ECs From Apoptosis
Because 14-3-3 binds and sequesters Bad 19 and cPGI 2 and L-165041 increase 14-3-3 protein levels, we determined whether 14-3-3 upregulation amplified Bad binding. ECs were treated with cPGI 2 , L-165041, or vehicle, and the cell lysate was immunoprecipitated with a 14-3-3 antibody. Bad proteins in the precipitate were analyzed by Western blots. Both cPGI 2 and L-165041 increased Bad binding to 14-3-3 ( Figure 6A ). In view of increased binding by 14-3-3, we anticipated that cPGI 2 and L-165041 suppress Bad translocation to mitochondria. To test this, we prepared mitochondrial fractions from ECs treated with and without H 2 O 2 , cPGI 2 , or L-165041. Hsp60 was included as a mitochondrial marker. The results show that H 2 O 2 increased Bad in the mitochondrial fraction consistent with Bad translocation ( Figure 6B ). Pretreatment of cells with cPGI 2 or L-165041 blocked H 2 O 2 -induced Bad translocation to mitochondria ( Figure 6B ). H 2 O 2 -induced Bad mitochondrial translocation resulted in increased cytochrome c release into cytosol, which was suppressed by cPGI 2 (supplemental Figure IV) . The role of 14-3-3 in regulating Bad-mediated apoptosis was further supported by 14-3-3 overexpression. Transfection of cells with 14-3-3 vector reduced H 2 O 2 -induced PARP cleavage to the basal level ( Figure 6C ). 14-3-3 overexpression also suppressed the basal PARP cleavage.
Discussion
Results from this study provide strong evidence for EC protection by PGI 2 . Authentic PGI 2 generated by Ad-COPI transduction and the synthetic cPGI 2 protected HUVECs and ECV304 cells from H 2 O 2 -induced apoptosis in a PPAR␦-dependent manner. Several pieces of evidence support the requirement of PPAR␦ activation for the antiapoptotic action of PGI 2 . First, HUVECs expressed functional PPAR␦, which prevented H 2 O 2 -induced apoptosis. Second, PPAR␦ suppression by siRNA abrogated the protective action of PGI 2 or L-165041. Third, overexpression of PPAR␦ amplified the antiapoptotic action of PGI 2 . It was reported that PPAR␦ protected keratinocytes from apoptosis by upregulating the expression of phosphoinositide-dependent kinase (PDK) and activation of Akt. 25 In this study, we evaluated the effect of PGI 2 and L-165041 on PDK-1 and Akt in HUVECs and did not detect changes in PDK-1 protein level or phosphorylated Akt (data not shown). In contrast, our results identified 14-3-3 as the PPAR␦-driven antiapoptotic gene. Ad-COPI, cPGI 2 , and L-165041 increased 14-3-3 protein expression, which was abrogated by PPAR␦ siRNA and enhanced by Ad-PPAR␦. Importantly, our results provide direct evidence for the first time for transcriptional activation of 14-3-3 by PPAR␦. These results demonstrate the requirement of PPREs for PGI 2 -induced 14-3-3 promoter activation because deletion of the PPREcontaining region of 14-3-3 promoter nullified the promoter response to Ad-COPI, Ad-PPAR␦, or their combination. Activated PPAR␦ forms a heterodimer with RXR and the heterodimer binds to PPREs, which comprise 2 identical hexamers with a single nucleotide in between via which transcription is activated. 26 The 5Ј-flanking promoter region of 14-3-3 harbors Figure 5 . PPAR␦-dependent activation of 14-3-3 promoter activity. A, ECV304 cells were transfected with 1.6-kb promoter construct with or without PPAR␦-siRNA, followed by cPGI 2 or L-165041. B, ECV304 cells transduced with the indicated Ad vector were transfected with wild-type or 5Ј-deletion mutants shown at the top. Each bar represents meanϮSD (nϭ3); **PϽ0.01. C, Chromatin immunoprecipitation analysis of PPAR␦ binding to 14-3-3 promoter. Binding was detected at Ϫ1625/Ϫ1328, which harbors PPREs but not at control Ϫ412/ϩ24.
3 canonical PPREs that are located contiguously between Ϫ1426 and Ϫ1477. Deletion of these PPREs results in loss of promoter response to cPGI 2 or L-165041. Our data show that cPGI 2 and L-165041 induced binding of PPAR␦ specifically to this promoter region in vivo. Together, the results indicate that 14-3-3 is a direct target of PPAR␦, and its transcriptional activation depends on PPAR␦ activation. Seven isoforms of 14-3-3 proteins have been identified in mammalian cells. They share sequence homology and biochemical properties. 17 Because 14-3-3 expression in ECs has not been reported, we analyzed their protein levels in HUVECs. Results show that basal 14-3-3␥ and 14-3-3 were detected at a higher density than other isoforms, and basal 14-3-3␤, , and were barely detectable. Because the affinity of antibodies for each isoform may vary, the isoform abundance cannot be accurately determined, and the data should be interpreted with caution. However, response to stimulation by PPAR␦ activation is clearly isoform specific. 14-3-3, and to a lesser extent 14-3-3, proteins are significantly upregulated by cPGI 2 or L-165041. 14-3-3 are cytosolic proteins serving as a scaffold to interact with a large number of proteins. 27 They play a role in protecting cells from apoptosis through their binding and sequestering phosphorylated Bad in cytosol. 19 Under apoptotic stimulation, Bad is dissociated from 14-3-3 and translocated to mitochondria, where it interacts with Bcl-XL and disrupts the protective function of Bcl-XL, resulting in outer membrane permeabilization, release of cytochrome c, and activation of caspase 9 and 3. 28 Our results confirm that H 2 O 2 induces Bad translocation to mitochondria in HUVECs, suggesting that the basal 14-3-3 protein levels were inadequate for preventing Bad translocation. Because cPGI 2 and L-165041 increase 14-3-3 and augment 14-3-3 binding of Bad, their prevention of Bad translocation is attributed to elevated 14-3-3. These findings reveal for the first time that constitutively expressed 14-3-3 is transcriptionally regulated by PPAR␦, and its upregulation confers resistance to the H 2 O 2 -induced apoptosis. Together, our findings shed light on a novel mechanism by which PGI 2 protects ECs from apoptosis. As illustrated in Figure 6D , we propose that PGI 2 binds and activates PPAR␦, which forms a heterodimer with RXR and binds to specific PPREs on 14-3-3 promoter. PPAR␦mediated 14-3-3 upregulation increases the capacity of 14-3-3 to bind and sequester Bad, thereby reducing Bad translocation to mitochondria and the consequent caspase 3 activation and apoptosis. It is important to note that this protective signaling pathway is enforced by a positive Figure 6 . Role of 14-3-3 in antiapoptosis. A, HUVECs were treated with cPGI 2 or L-165041 for 4 hours. Cell lysates were immunoprecipitated with 14-3-3 antibody, and Bad in immunoprecipitation was analyzed. B, HUVECs were treated as indicated, and Bad and Hsp60 in mitochondrial fraction was analyzed. C, ECV304 cells transfected with the indicated vectors were treated with H 2 O 2 . Cleaved PARP was analyzed by Western blots. D, Schematic illustration of the protective mechanism of PGI 2 via PPAR␦-dependent 14-3-3 upregulation. feedback regulation. Our results show that cPGI 2 and L-165041 increased PPAR␦ protein levels by Ϸ3-fold. To our knowledge, the positive feedback regulation of PPAR␦ expression has not reported previously, and the mechanism by which this occurs is unclear. Nevertheless, feedback upregulation of PPAR␦ by its ligands is important in amplifying the PPAR␦314-3-3 protection program.
To demonstrate the antiapoptotic action of PGI 2 , we transduced HUVECs with Ad-COPI, which selectively increased PGI 2 production. The results show a consistent inhibition of H 2 O 2 -induced annexin V-positive and Hoechst-positive cells and caspase 3 activation. cPGI 2 had a similar effect as Ad-COPI, except that high concentrations of cPGI 2 were required to inhibit H 2 O 2 -induced apoptosis. One intriguing question is whether the intracellularly produced PGI 2 by Ad-COPI acts directly on PPAR␦ without secretion into the extracellular milieu. It has been shown that PPAR␦ is distributed in cytosol and nucleus of ECs. 29 Because intracellular PGI 2 is produced at the perinuclear membrane, PGI 2 may bind cytosolic PPAR␦ and facilitates its translocation or, alternatively, may enter nucleus, where it binds and activates PPAR␦. There is little published data on this issue, which requires further investigation. Ad-COPI gene transfer has been shown to protect neurons from ischemia-reperfusion injury in vivo, 30 which may be attributed to the antiapoptotic action of PGI 2 . This gene transfer approach has potential for protecting blood vessels and treating vascular diseases.
